Literature DB >> 15071018

Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material.

Thomas J Novicki1, Jeffrey M Schapiro, Bruce K Ulness, Ann Sebeste, Laurel Busse-Johnston, Kristine M Swanson, Susan R Swanzy, Wendy Leisenring, Ajit P Limaye.   

Abstract

Studies have shown that vancomycin broth enrichment is superior to direct plating for the detection of vancomycin-resistant enterococcus (VRE), but vancomycin selective broth is not generally commercially available. We developed an easy-to-prepare VRE selective differential broth and compared it to direct plating on bile esculin azide (BEA) agar for the isolation of VRE from fecal samples. A total of 528 consecutive rectal swabs and stools were inoculated onto BEA agar and into BEA broth with vancomycin at a concentration of 15 microg/ml (BEA VAN15 microg/ml broth). After 1 to 2 days of incubation, broths were subcultured to BEA VAN6 microg/ml agar. Bile esculin-positive colonies from the direct and broth subculture plates were evaluated for the presence of VRE by standard microbiological techniques. Addition of the broth enrichment step led to the detection of significantly more VRE isolates than did direct plating alone (28 versus 18 VRE isolates, respectively). In all, 30 VRE strains were isolated from 29 cultures, all of which were Enterococcus faecium. MICs of vancomycin ranged from 32 microg/ml (n = 2) to > 256 microg/ml (n = 28). Twenty-two VRE isolates were available for further testing: sixteen exhibited a VanA phenotype and six were of the VanB phenotype. van genotypes were in agreement with phenotypes for all VRE isolates except one, which could not be genotyped. The broth method also resulted in significantly fewer bile esculin-positive, non-VRE isolates requiring further workup. We have thus developed an easily prepared vancomycin selective differential broth that is significantly more sensitive and specific in the detection of VRE than is direct fecal plating to BEA agar.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071018      PMCID: PMC387614          DOI: 10.1128/JCM.42.4.1637-1640.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001.

Authors: 
Journal:  Am J Infect Control       Date:  2001-12       Impact factor: 2.918

2.  High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci.

Authors:  Erika M C D'Agata; Shiva Gautam; William K Green; Yi-Wei Tang
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

3.  A PCR assay for rapid detection of vancomycin-resistant enterococci.

Authors:  X Pérez-Hernández; S Méndez-Alvarez; F Claverie-Martín
Journal:  Diagn Microbiol Infect Dis       Date:  2002-04       Impact factor: 2.803

4.  Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

Authors:  K Gambarotto; M C Ploy; P Turlure; C Grélaud; C Martin; D Bordessoule; F Denis
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 5.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

6.  Detection and typing of vancomycin-resistance genes of enterococci from clinical and nosocomial surveillance specimens by multiplex PCR.

Authors:  J J Lu; C L Perng; T S Chiueh; S Y Lee; C H Chen; F Y Chang; C C Wang; W M Chi
Journal:  Epidemiol Infect       Date:  2001-06       Impact factor: 2.451

7.  Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands.

Authors:  N van den Braak; A Ott; A van Belkum; J A Kluytmans; J G Koeleman; L Spanjaard; A Voss; A J Weersink; C M Vandenbroucke-Grauls; A G Buiting; H A Verbrugh; H P Endtz
Journal:  Infect Control Hosp Epidemiol       Date:  2000-08       Impact factor: 3.254

Review 8.  Recommendations for preventing the spread of vancomycin resistance.

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  1995-02       Impact factor: 3.254

9.  Evaluation of selective and enrichment media for isolation of glycopeptide-resistant enterococci from faecal specimens.

Authors:  Derek F J Brown; Enid Walpole
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

10.  Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay.

Authors:  Silvano Palladino; Ian D Kay; James P Flexman; Ingrid Boehm; Anna Maria G Costa; Erica J Lambert; Keryn J Christiansen
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more
  11 in total

1.  Evaluation of a new chromogenic medium, ChromID VRE, for detection of vancomycin-resistant Enterococci in stool samples and rectal swabs.

Authors:  Julien Delmas; Frédéric Robin; Cédric Schweitzer; Olivier Lesens; Richard Bonnet
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

2.  Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.

Authors:  A Matsushima; S Takakura; M Yamamoto; Y Matsumura; M Shirano; M Nagao; Y Ito; Y Iinuma; T Shimizu; N Fujita; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-04       Impact factor: 3.267

3.  Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs.

Authors:  Amos Adler; Shiri Navon-Venezia; Jacob Moran-Gilad; Evgeniya Marcos; David Schwartz; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

4.  Comparison of PCR and culture for screening of vancomycin-resistant Enterococci: highly disparate results for vanA and vanB.

Authors:  Anton Mak; Mark A Miller; George Chong; Yury Monczak
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

5.  Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.

Authors:  Paul D Stamper; Mian Cai; Clara Lema; Kim Eskey; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-08-17       Impact factor: 5.948

6.  Novel chromogenic medium for detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

Authors:  Gaëlle Cuzon; Thierry Naas; Nicolas Fortineau; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

7.  Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs.

Authors:  Yesim Cekin; Aylin Erman Daloğlu; Dilara Oğünç; Betil Ozhak Baysan; Duygu Dağlar; Dilara Inan; Derya Mutlu; Gözde Ongüt; Dilek Colak
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

8.  Detection of Vancomycin Resistant Enterococci from Rectal Swab Samples by Becton-Dickinson GeneOhm VanR assay and Culture at ICU of a Tertiary Care Center in Turkey.

Authors:  Ayhan Gozaydin; Sukran Kose; Gulfem Ece; Gursel Ersan; Mustafa Gonullu
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

9.  Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary.

Authors:  Dorottya Franyó; Balázs Kocsi; Evelin Erzsébet Bukta; Judit Szabó; Zsuzsanna Dombrádi
Journal:  Folia Microbiol (Praha)       Date:  2019-11-04       Impact factor: 2.099

10.  Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.

Authors:  Ojan Assadian; Mehrdad Askarian; Maria Stadler; Soheila Shaghaghian
Journal:  BMC Infect Dis       Date:  2007-06-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.